The importance of tumour angiogenesis in CCRCC development and spreading has been recently strongly validated by the proven efficacy of antiangiogenic drugs that target mainly the VHL/VEGF pathway (Motzer et al, 2007; Figlin et al, 2008). The gene discussed is VHL; the disease is neoplasm.